Analyzing BioHarvest Sciences (BHST) and Its Competitors

BioHarvest Sciences (NASDAQ:BHST) is one of 1,068 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare BioHarvest Sciences to similar companies based on the strength of its valuation, dividends, institutional ownership, earnings, risk, profitability and analyst recommendations.

Volatility and Risk

BioHarvest Sciences has a beta of 2.67, suggesting that its share price is 167% more volatile than the S&P 500. Comparatively, BioHarvest Sciences’ competitors have a beta of 3.67, suggesting that their average share price is 267% more volatile than the S&P 500.

Insider and Institutional Ownership

44.1% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 13.6% of shares of all “Pharmaceutical preparations” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for BioHarvest Sciences and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	0	0	2	0	3.00
BioHarvest Sciences Competitors	8148	21805	49613	1310	2.55

BioHarvest Sciences currently has a consensus price target of $13.00, indicating a potential upside of 136.36%. As a group, “Pharmaceutical preparations” companies have a potential upside of 243.25%. Given BioHarvest Sciences’ competitors higher probable upside, analysts plainly believe BioHarvest Sciences has less favorable growth aspects than its competitors.

Profitability

This table compares BioHarvest Sciences and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-76.65%	N/A	-85.16%
BioHarvest Sciences Competitors	-3,409.82%	-235.83%	-32.89%

Valuation & Earnings

This table compares BioHarvest Sciences and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
BioHarvest Sciences	$12.67 million	-$12.56 million	-4.40
BioHarvest Sciences Competitors	$9.55 billion	$137.66 million	-7.44

BioHarvest Sciences’ competitors have higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

BioHarvest Sciences competitors beat BioHarvest Sciences on 8 of the 12 factors compared.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.